organization · Reporting owner
Insight Venture Associates X, Ltd.
Disclosed activity across 5 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Tenable Holdings, Inc.TENB · Entity 4063 | 10% owner | November 03, 2020 | February 08, 2021 |
| nCino OpCo, Inc.NCNO · Entity 15709 | 10% owner | January 13, 2021 | January 15, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Tenable Holdings, Inc.
Report date November 03, 2020 · Filed February 08, 2021
Jointly reported with Insight Holdings Group, LLC, Insight Venture Associates IX, Ltd., Insight Venture Associates IX, L.P., Insight Venture Partners IX, L.P., Insight Venture Partners (Cayman) IX, L.P., Insight Venture Partners (Delaware) IX, L.P., Insight Venture Partners IX (Co-Investors), L.P., IVP (Venice), L.P., IVP GP (Venice), LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2020-11-03 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-11-03 · Sale · Disposed 25,699 · Balance 0 F6: See Exhibit 99.1 F1: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 4,036,162 |
Reported balance
After 2020-11-09 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-11-09 · Sale · Disposed 2,393 · Balance 4,036,162 F7: See Exhibit 99.1 F2: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 2,005,470 |
Reported balance
After 2020-11-09 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2020-11-09 · Sale · Disposed 1,189 · Balance 2,005,470 F7: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 427,630 |
Reported balance
After 2020-11-09 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2020-11-09 · Sale · Disposed 254 · Balance 427,630 F7: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 80,564 |
Reported balance
After 2020-11-09 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2020-11-09 · Sale · Disposed 48 · Balance 80,564 F7: See Exhibit 99.1 F5: See Exhibit 99.1 |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1
F2: See Exhibit 99.1
F3: See Exhibit 99.1
F4: See Exhibit 99.1
F5: See Exhibit 99.1
F6: See Exhibit 99.1
F7: See Exhibit 99.1
nCino OpCo, Inc.
Report date January 13, 2021 · Filed January 15, 2021
Jointly reported with Insight Holdings Group, LLC, Insight Venture Associates IX, Ltd., Insight Venture Associates IX, L.P., Insight Venture Partners IX, L.P., Insight Venture Partners (Cayman) IX, L.P., Insight Venture Partners (Delaware) IX, L.P., Insight Venture Partners IX (Co-Investors), L.P., IVP (Venice), L.P., IVP GP (Venice), LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 10,310,944 |
Reported balance
After 2021-01-13 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-01-13 · Other · Disposed 660,929 · Balance 10,310,944 F1: See Exhibit 99.1 F2: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 5,123,257 |
Reported balance
After 2021-01-13 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-01-13 · Other · Disposed 328,400 · Balance 5,123,257 F1: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,092,443 |
Reported balance
After 2021-01-13 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2021-01-13 · Other · Disposed 70,025 · Balance 1,092,443 F1: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 205,816 |
Reported balance
After 2021-01-13 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2021-01-13 · Other · Disposed 13,193 · Balance 205,816 F1: See Exhibit 99.1 F5: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 9,547 |
Reported balance
After 2021-01-13 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2021-01-13 · Other · Acquired 9,547 · Balance 9,547 F1: See Exhibit 99.1 F6: See Exhibit 99.1 |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1
F2: See Exhibit 99.1
F3: See Exhibit 99.1
F4: See Exhibit 99.1
F5: See Exhibit 99.1
F6: See Exhibit 99.1
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hinge Health, Inc.
Report date July 07, 2026 · Filed July 10, 2026
Jointly reported with Insight Holdings Group, LLC, Insight Venture Associates X, L.P., Insight Venture Partners (Cayman) X, L.P., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X (Co-Investors), L.P., Insight Venture Partners X, L.P.
Section 16 reporting ended · disclosed 2026-07-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 122,188 |
Reported balance
After 2026-07-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-07-07 · Conversion · Acquired 122,188 · Balance 122,188 F8: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 2,907 |
Reported balance
After 2026-07-07 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2026-07-07 · Conversion · Acquired 2,907 · Balance 2,907 F8: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 100,195 |
Reported balance
After 2026-07-07 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2026-07-07 · Conversion · Acquired 100,195 · Balance 100,195 F8: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 19,382 |
Reported balance
After 2026-07-07 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2026-07-07 · Conversion · Acquired 19,382 · Balance 19,382 F8: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-07 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2026-07-07 · Sale · Disposed 122,188 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-07 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2026-07-07 · Sale · Disposed 2,907 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-07 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2026-07-07 · Sale · Disposed 100,195 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-07 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2026-07-07 · Sale · Disposed 19,382 · Balance 0 F12: See Exhibit 99.1 F9: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 90,640 |
Reported balance
After 2026-07-09 transaction · row 9
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 9 · 2026-07-09 · Conversion · Acquired 90,640 · Balance 90,640 F8: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 2,156 |
Reported balance
After 2026-07-09 transaction · row 10
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 10 · 2026-07-09 · Conversion · Acquired 2,156 · Balance 2,156 F8: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 74,325 |
Reported balance
After 2026-07-09 transaction · row 11
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 11 · 2026-07-09 · Conversion · Acquired 74,325 · Balance 74,325 F8: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 14,378 |
Reported balance
After 2026-07-09 transaction · row 12
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 12 · 2026-07-09 · Conversion · Acquired 14,378 · Balance 14,378 F8: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 2,792 |
Reported balance
After 2026-07-09 transaction · row 13
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 13 · 2026-07-09 · Sale · Disposed 87,848 · Balance 2,792 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 66 |
Reported balance
After 2026-07-09 transaction · row 14
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 14 · 2026-07-09 · Sale · Disposed 2,090 · Balance 66 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 2,289 |
Reported balance
After 2026-07-09 transaction · row 15
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 15 · 2026-07-09 · Sale · Disposed 72,036 · Balance 2,289 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 443 |
Reported balance
After 2026-07-09 transaction · row 16
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 16 · 2026-07-09 · Sale · Disposed 13,935 · Balance 443 F12: See Exhibit 99.1 F10: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-09 transaction · row 17
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 17 · 2026-07-09 · Sale · Disposed 2,792 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-09 transaction · row 18
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 18 · 2026-07-09 · Sale · Disposed 66 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-09 transaction · row 19
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 19 · 2026-07-09 · Sale · Disposed 2,289 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2026-07-09 transaction · row 20
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 20 · 2026-07-09 · Sale · Disposed 443 · Balance 0 F12: See Exhibit 99.1 F11: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 3,094,820 |
Reported balance
After 2026-07-07 transaction · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · 2026-07-07 · Conversion · Disposed 122,188 · Balance 3,094,820 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 73,638 |
Reported balance
After 2026-07-07 transaction · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · 2026-07-07 · Conversion · Disposed 2,907 · Balance 73,638 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 2,537,790 |
Reported balance
After 2026-07-07 transaction · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · 2026-07-07 · Conversion · Disposed 100,195 · Balance 2,537,790 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 490,910 |
Reported balance
After 2026-07-07 transaction · row 24
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 24 · 2026-07-07 · Conversion · Disposed 19,382 · Balance 490,910 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 3,004,180 |
Reported balance
After 2026-07-09 transaction · row 25
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 25 · 2026-07-09 · Conversion · Disposed 90,640 · Balance 3,004,180 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F1: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 71,482 |
Reported balance
After 2026-07-09 transaction · row 26
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 26 · 2026-07-09 · Conversion · Disposed 2,156 · Balance 71,482 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F2: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 2,463,465 |
Reported balance
After 2026-07-09 transaction · row 27
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 27 · 2026-07-09 · Conversion · Disposed 74,325 · Balance 2,463,465 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F3: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnotes | 476,532 |
Reported balance
After 2026-07-09 transaction · row 28
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 28 · 2026-07-09 · Conversion · Disposed 14,378 · Balance 476,532 F8: See Exhibit 99.1 F5: See Exhibit 99.1 F4: See Exhibit 99.1 F6: See Exhibit 99.1 F7: See Exhibit 99.1 |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1
F2: See Exhibit 99.1
F3: See Exhibit 99.1
F4: See Exhibit 99.1
F5: See Exhibit 99.1
F6: See Exhibit 99.1
F7: See Exhibit 99.1
F8: See Exhibit 99.1
F9: See Exhibit 99.1
F10: See Exhibit 99.1
F11: See Exhibit 99.1
F12: See Exhibit 99.1
SentinelOne, Inc.
Report date April 01, 2024 · Filed April 04, 2024
Jointly reported with Insight Holdings Group, LLC, Insight Venture Associates X, L.P., Insight Venture Partners (Cayman) X, L.P., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X (Co-Investors), L.P., Insight Venture Partners X, L.P.
Section 16 reporting ended · disclosed 2024-04-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,933,556 |
Reported balance
After 2024-04-01 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-04-01 · Conversion · Acquired 3,933,556 · Balance 3,933,556 F1: See Exhibit 99.1 F2: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,225,563 |
Reported balance
After 2024-04-01 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2024-04-01 · Conversion · Acquired 3,225,563 · Balance 3,225,563 F1: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 623,954 |
Reported balance
After 2024-04-01 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2024-04-01 · Conversion · Acquired 623,954 · Balance 623,954 F1: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 93,593 |
Reported balance
After 2024-04-01 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2024-04-01 · Conversion · Acquired 93,593 · Balance 93,593 F1: See Exhibit 99.1 F5: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,887,664 |
Reported balance
After 2024-04-01 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2024-04-01 · Sale · Disposed 45,892 · Balance 3,887,664 F6: See Exhibit 99.1 F2: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 3,187,931 |
Reported balance
After 2024-04-01 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2024-04-01 · Sale · Disposed 37,632 · Balance 3,187,931 F6: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 616,675 |
Reported balance
After 2024-04-01 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2024-04-01 · Sale · Disposed 7,279 · Balance 616,675 F6: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 92,501 |
Reported balance
After 2024-04-01 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2024-04-01 · Sale · Disposed 1,092 · Balance 92,501 F6: See Exhibit 99.1 F5: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnote | 8,621,691 |
Reported balance
After 2024-04-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2024-04-01 · Conversion · Disposed 3,933,556 · Balance 8,621,691 F1: See Exhibit 99.1 F2: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnote | 7,069,890 |
Reported balance
After 2024-04-01 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2024-04-01 · Conversion · Disposed 3,225,563 · Balance 7,069,890 F1: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnote | 1,367,601 |
Reported balance
After 2024-04-01 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2024-04-01 · Conversion · Disposed 623,954 · Balance 1,367,601 F1: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Class B Common StockSEC Table II · derivative / convertible security | IndirectSee footnote | 205,141 |
Reported balance
After 2024-04-01 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2024-04-01 · Conversion · Disposed 93,593 · Balance 205,141 F1: See Exhibit 99.1 F5: See Exhibit 99.1 |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1
F2: See Exhibit 99.1
F3: See Exhibit 99.1
F4: See Exhibit 99.1
F5: See Exhibit 99.1
F6: See Exhibit 99.1
nCino, Inc.
Report date December 09, 2024 · Filed December 11, 2024
Jointly reported with Insight Holdings Group, LLC, Insight SN Holdings 2, LLC, Insight SN Holdings, LLC, Insight Venture Associates X, L.P., Insight Venture Partners (Cayman) X, L.P., Insight Venture Partners (Delaware) X, L.P., Insight Venture Partners X, L.P., Insight Venture Partners X (Co-Investors), L.P.
Section 16 reporting ended · disclosed 2024-12-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 340,399 |
Reported balance
After 2024-12-09 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-12-09 · Sale · Disposed 21,892 · Balance 340,399 F1: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 999,315 |
Reported balance
After 2024-12-09 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2024-12-09 · Sale · Disposed 37,277 · Balance 999,315 F1: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 193,308 |
Reported balance
After 2024-12-09 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2024-12-09 · Sale · Disposed 7,211 · Balance 193,308 F1: See Exhibit 99.1 F5: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 907,255 |
Reported balance
After 2024-12-09 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2024-12-09 · Sale · Disposed 24,649 · Balance 907,255 F1: See Exhibit 99.1 F6: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 286,590 |
Reported balance
After 2024-12-10 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2024-12-10 · Sale · Disposed 53,809 · Balance 286,590 F2: See Exhibit 99.1 F3: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 907,693 |
Reported balance
After 2024-12-10 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2024-12-10 · Sale · Disposed 91,622 · Balance 907,693 F2: See Exhibit 99.1 F4: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 175,585 |
Reported balance
After 2024-12-10 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2024-12-10 · Sale · Disposed 17,723 · Balance 175,585 F2: See Exhibit 99.1 F5: See Exhibit 99.1 |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 846,672 |
Reported balance
After 2024-12-10 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2024-12-10 · Sale · Disposed 60,583 · Balance 846,672 F2: See Exhibit 99.1 F6: See Exhibit 99.1 |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1
F2: See Exhibit 99.1
F3: See Exhibit 99.1
F4: See Exhibit 99.1
F5: See Exhibit 99.1
F6: See Exhibit 99.1
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 29, 2026 Filed Jun 30, 2026 01:27 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 17,427 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 2 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 17,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 01:27 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 732,444 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000691 · form4.xml · nonDerivative · entry 1 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 732,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:27 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 116,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000691 · form4.xml · derivative · entry 28 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 510,292 Underlying: Class A Common Stock · 116,183 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:27 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 600,613 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000691 · form4.xml · derivative · entry 27 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 2,637,985 Underlying: Class A Common Stock · 600,613 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:27 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 17,427 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000691 · form4.xml · derivative · entry 26 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 76,545 Underlying: Class A Common Stock · 17,427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:27 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 732,444 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000691 · form4.xml · derivative · entry 25 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 3,217,008 Underlying: Class A Common Stock · 732,444 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 42,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · derivative · entry 20 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 626,475 Underlying: Class A Common Stock · 42,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 217,442 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · derivative · entry 19 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 3,238,598 Underlying: Class A Common Stock · 217,442 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 6,309 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · derivative · entry 18 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 93,972 Underlying: Class A Common Stock · 6,309 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 265,169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · derivative · entry 17 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 3,949,452 Underlying: Class A Common Stock · 265,169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 2,695 | $73.19 | $197,256.48 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 16 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 13,930 | $73.19 | $1,019,585.46 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 15 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 403 | $73.19 | $29,496.98 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 14 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 16,988 | $73.19 | $1,243,411.18 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 13 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 0 F12 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 4,422 | $72.85 | $322,146.68 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 12 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 2,695 F12 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 22,861 | $72.85 | $1,665,444.42 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 11 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 13,930 F12 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 664 | $72.85 | $48,373.00 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 10 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 403 F12 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 27,879 | $72.85 | $2,031,010.24 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 9 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 16,988 F12 · kind: See Exhibit 99.1 F10 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 34,945 | $71.59 | $2,501,639.17 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 8 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 7,117 F12 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 180,651 | $71.59 | $12,932,425.72 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 7 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 36,791 F12 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 5,242 | $71.59 | $375,263.77 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 6 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 1,067 F12 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 220,302 | $71.59 | $15,770,957.55 |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 5 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 44,867 F12 · kind: See Exhibit 99.1 F9 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 42,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 4 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 42,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 217,442 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 3 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 217,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 6,309 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 2 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 6,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 25, 2026 Filed Jun 30, 2026 01:25 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 265,169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899140-26-000690 · form4.xml · nonDerivative · entry 1 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 265,169 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:57 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 23,067 | $71.67 | $1,653,140.38 |
DisclosureSEC source: 0001104659-26-077467 · tm2618953-2_4seq1.xml · nonDerivative · entry 2 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F6 · kind: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:57 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 119,244 | $71.67 | $8,545,847.82 |
DisclosureSEC source: 0001104659-26-077467 · tm2618953-2_4seq1.xml · nonDerivative · entry 1 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F6 · kind: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 42,240 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 42 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 668,537 Underlying: Class A Common Stock · 42,240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 218,362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 41 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 3,456,040 Underlying: Class A Common Stock · 218,362 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 6,336 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 40 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 100,281 Underlying: Class A Common Stock · 6,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 266,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 39 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 4,214,621 Underlying: Class A Common Stock · 266,290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 3,460 | $71.67 | $247,967.47 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 30 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F13 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 145,417 | $71.67 | $10,421,585.60 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 29 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F13 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 19,173 | $70.84 | $1,358,140.55 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 28 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 23,067 F14 · kind: See Exhibit 99.1 F12 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 99,118 | $70.84 | $7,021,132.56 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 27 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 119,244 F14 · kind: See Exhibit 99.1 F12 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 2,876 | $70.84 | $203,724.62 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 26 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 3,460 F14 · kind: See Exhibit 99.1 F12 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 120,873 | $70.84 | $8,562,171.92 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 25 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 145,417 F14 · kind: See Exhibit 99.1 F12 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 42,240 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 24 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 42,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 218,362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 23 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 218,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 6,336 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 22 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 6,336 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 24, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 266,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 21 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 266,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 8,910 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 38 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 710,777 Underlying: Class A Common Stock · 8,910 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 46,060 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 37 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 3,674,402 Underlying: Class A Common Stock · 46,060 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 1,336 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 36 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 106,617 Underlying: Class A Common Stock · 1,336 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 56,171 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · derivative · entry 35 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See footnotes Disclosed balance after: 4,480,911 Underlying: Class A Common Stock · 56,171 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: See Exhibit 99.1 F5 · price: See Exhibit 99.1 F8 · derivative.exercise_date: See Exhibit 99.1 F8 · derivative.expiration_date: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 8,910 | $70.21 | $625,611.20 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 20 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F4 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 46,060 | $70.21 | $3,234,079.87 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 19 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F3 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 1,336 | $70.21 | $93,806.57 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 18 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F2 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 01:56 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 56,171 | $70.21 | $3,944,018.68 |
DisclosureSEC source: 0001104659-26-077466 · tm2618953-1_4seq1.xml · nonDerivative · entry 17 Insight Holdings Group, LLC · CIK 0001305473 · 10% owner Insight Venture Associates X, Ltd. · CIK 0001803240 · 10% owner Insight Venture Associates X, L.P. · CIK 0001844845 · 10% owner Insight Venture Partners X, L.P. · CIK 0001710959 · 10% owner Insight Venture Partners (Cayman) X, L.P. · CIK 0001710860 · 10% owner Insight Venture Partners (Delaware) X, L.P. · CIK 0001710835 · 10% owner Insight Venture Partners X (Co-Investors), L.P. · CIK 0001710834 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · See Footnotes Disclosed balance after: 0 F14 · kind: See Exhibit 99.1 F11 · price: See Exhibit 99.1 F1 · ownership.nature: See Exhibit 99.1 F6 · ownership.nature: See Exhibit 99.1 F7 · ownership.nature: See Exhibit 99.1 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.